OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Optimizing these processes involves fine-tuning various variables, including cell line development, media formulation, and bioreactor settings. A key goal is to amplify antibody titer while minimizing production costs a